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one million patients would protect 50 000 people from
death or disability. Large scale randomised controlled
trials have the potential to make an important
contribution to the prevention of death and disability
from this growing epidemic.16 17
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Suicidal ideation among outpatients at general neurology
clinics: prospective study
Alan J Carson, Steven Best, Charles Warlow, Michael Sharpe
Suicide is one of the ten most common causes of death
for both men and women in Great Britain.1 Psychiatric
disorders are the main risk factor, but numerous studies
have also identified physical illness as an important con›
tributory factor.1 2 Although it is considered mandatory
to enquire about suicidal ideation in psychiatric consul›
tations, this is seldom part of a medical assessment. We
aimed to examine suicidal ideation in a consecutive
series of patients who had been newly referred to
general neurology outpatient clinics. The study was
approved by the local research ethics committee.
Participants, methods, and results
As part of another study,3 300 of 312 consecutive new
patients at the general neurology outpatient clinics at
the Western General Hospital, Edinburgh, were
interviewed using the primary care evaluation of men›
tal disorders (PRIME›MD) structured psychiatric inter›
view schedule.4 As part of the interview all patients
were asked: “In the last two weeks, have you had
thoughts that you would be better off dead or of hurt›
ing yourself in some way?”
Patients who answered yes were asked to describe
the nature of these thoughts. To be classed as
experiencing suicidal ideation the patient had to have
thought about active plans for committing suicide—
such as buying tablets—nearly every day for the
previous two weeks. Whenever a patient reported such
ideation the general practitioner was informed.
Diagnoses of anxiety and depressive disorders that
were made using the structured interview were also
recorded. After the clinical consultation, the neurolo›
gists recorded the neurological diagnosis and whether
the patient required psychiatric or psychological
assessment or treatment.
Before a patient attended the clinic the patient’s
general practitioner was sent a brief questionnaire. The
general practitioners were asked to indicate whether
they believed that the patient required psychiatric or
psychological assessment or treatment.
At the time of assessment the researchers were
blind to the opinions of the neurologists and the
general practitioners.
The clinical characteristics of the patients attending
the clinics are shown in the table. One in 11 patients
(26/300) seen at the general neurology clinics had
given serious thought to committing suicide in the past
two weeks. Almost all of these patients (23/26) had
major depression. It might be assumed that suicidal
ideation would be more likely to occur in patients with
progressive, debilitating neurological conditions. How›
ever, this was not the case. Twelve of the 26 patients
who had experienced suicidal ideation had medically
unexplained symptoms, and most of the remainder
had non›progressive conditions.
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Comment
Our findings do not support the view that suicidal idea›
tion occurring in neurology patients is largely a rational
response to progressive physical illness. Instead, the
findings underscore the importance of major depressive
disorder in influencing the ways that medically ill
patients think about their illnesses and themselves.
The prevalence of 9% (95% confidence interval 6%
to 12%) for significant suicidal ideation described in
this study is higher than the 2›3% described as
occurring in primary care and community settings in
the United States.5 We are unaware of any data that
indicate what proportion of those who are medically ill
and who report suicidal ideation actually go on to kill
themselves. None the less, suicidal ideation of the type
considered important in this study is clinically
significant: it would be taken seriously during a psychi›
atric consultation.
It is encouraging that 58% of those patients with
suicidal ideation were identified by either the general
practitioner or the neurologist as needing psychiatric or
psychological assessment or treatment. However,
general practitioners and neurologists did not always
identify the same patients. This highlights the
importance of assessing the mental state of medically ill
patients and the importance of communication of the
findings between general practitioners and specialists.
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Home collection of urine for culture from infants by
three methods: survey of parents’ preferences and
bacterial contamination rates
Lynster C T Liaw, Deepa M Nayar, Stephen J Pedler, Malcolm G Coulthard
Urinary tract infection is common in childhood.
Infants are most likely to scar and often have
non›specific symptoms. Because of practical difficulties
with collecting urine, samples are often not obtained.1
Most samples are collected by parents,2 yet nobody has
sought parents’ views on available methods. We
assessed contamination rates and parents’ opinions of
three common methods used at home.
Subject, methods, and results
Parents of children aged 1 to 18 months volunteered to
collect urine at home by pads, bags, and clean catch in a
randomised order, on one day. The study had ethics
committee approval. Demonstrations and instruction
sheets were given. Parents washed their hands before
each procedure and the child’s perineum before each
collection. Pads (Newcastle sterile urine collection packs,
Ontex UK, Corby) were placed inside the nappy and
checked every 10 minutes until wet (but not soiled), then
urine aspirated with a syringe. Bags (Hollister U›Bag,
Hollister, Libertyville, IL) were applied and inspected
every 10 minutes and removed to decant the urine. For
clean catch samples, infants were nursed with a sterile
bottle ready. Samples were immediately instilled on to
dipslides (Till›U›Test, Dimanco, Bedfordshire) with ster›
ile swabsticks and returned with forms recording
parents’ collection times, comments, and rankings.
Equipment costs were: pads 40 pence for 10 (or 59p for
a pack containing syringe, bottle, and two pads); bag
89p; sterile bottle 7p; dipslide and swabstick 59p.
Forty four parents attempted collections (29 boys,
median age 4 months, range 1 to 18 months). No sam›
ples were obtained from one baby with diarrhoea, and
no other child had a urine infection. Bacterial counts
were < 104/ml (typically reported as “insignificant” or
“no growth”) from 31 (70%) pads, 29 (66%) bags, and
33 (75%) clean catch collections. Seven samples from
pads, eight from bags, and one from clean catch collec›
tion had contamination ( > 104/ml of one or more
Clinical characteristics of new patients attending neurology outpatient clinics. Values are
numbers (percentages) unless indicated otherwise
Patients with
suicidal ideation*
(n=26)
Patients without
suicidal ideation
(n=274)
Relative risk
(95% CI)
Men 12 (46) 114 (42) 1.11 (0.71 to 1.72)
Women 14 (54) 160 (58) 0.84 (0.40 to 1.76)
Age <40 years 15 (58) 128 (47) 1.50 (0.71 to 3.15)
Has medically unexplained symptoms 12 (46) 78 (28) 1.62 (1.03 to 2.56)
Has non›progressive neurological disease† 12 (46) 153 (56) 0.83 (0.54 to 1.27)
Has potentially progressive neurological
disease‡
2 (8) 43 (16) 0.49 (0.13 to 1.91)
Major depressive disorder diagnosed 23 (88) 54 (20) 4.49 (3.40 to 5.92)
Identified as needing psychiatric assessment:§
By general practitioner 8 (31) 43 (16) NA
By neurologist 12 (46) 40 (15) NA
Not identified 11 (42) 170 (62) NA
NA=not applicable.
*Prevalence is 9% (95% CI 6% to 12%).
†Includes conditions such as epilepsy, headache, migraine, and neuropathy.
‡Includes conditions such as multiple sclerosis, Parkinson’s disease, and brain tumours.
§Not specifically identified as being suicidal.
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